AIMS AND METHODS: Minocycline (Mino) and doxycycline (Dox) are second generation tetracyclines known to present several other effects, which are independent from their antimicrobial activities. We studied in a comparative way the anti-inflammatory effects of Mino and Dox, on acute models of peripheral inflammation in rodents (formalin test and peritonitis in mice, and carrageenan-induced paw oedema in rats). Immunohistochemical assays for TNF-alpha and iNOS in rat paws of carrageenan-induced oedema were also carried out as well as in vitro assays for myeloperoxidase (MPO) and lactate dehydrogenase (LDH). Furthermore, antioxidant activities were evaluated by the DPPH assay. RESULTS: In the formalin test although Mino and Dox (1, 5, 10 and 25 mg/kg, i.p.) inhibited the first phase, they acted predominantly on the second phase of the test, where inhibition of the licking time close to 80% were observed. Mino and Dox were very efficacious in reducing the carrageenan-induced paw oedema in rats (10, 25 and 50 mg/kg, i.p.) and carrageenan-induced leucocyte migration (1 and 5 mg/kg, i.p.) to mice peritoneal cavities. Besides, they also significantly inhibited MPO and LDH releases at doses ranging from 0.001 to 1 μg/ml. Thus, in general, the anti-inflammatory activity of Dox was higher as compared to that of Mino, although the radical scavenging activity of Mino was of a magnitude 10 times higher. CONCLUSIONS: Our data indicate that anti-inflammatory and antioxidant effects, involve the inhibition of iNOS and TNF-alpha, among other properties, and these encourage clinical studies of these compounds for new therapeutic applications, especially those were inflammation plays a role.
AIMS AND METHODS: Minocycline (Mino) and doxycycline (Dox) are second generation tetracyclines known to present several other effects, which are independent from their antimicrobial activities. We studied in a comparative way the anti-inflammatory effects of Mino and Dox, on acute models of peripheral inflammation in rodents (formalin test and peritonitis in mice, and carrageenan-induced paw oedema in rats). Immunohistochemical assays for TNF-alpha and iNOS in rat paws of carrageenan-induced oedema were also carried out as well as in vitro assays for myeloperoxidase (MPO) and lactate dehydrogenase (LDH). Furthermore, antioxidant activities were evaluated by the DPPH assay. RESULTS: In the formalin test although Mino and Dox (1, 5, 10 and 25 mg/kg, i.p.) inhibited the first phase, they acted predominantly on the second phase of the test, where inhibition of the licking time close to 80% were observed. Mino and Dox were very efficacious in reducing the carrageenan-induced paw oedema in rats (10, 25 and 50 mg/kg, i.p.) and carrageenan-induced leucocyte migration (1 and 5 mg/kg, i.p.) to mice peritoneal cavities. Besides, they also significantly inhibited MPO and LDH releases at doses ranging from 0.001 to 1 μg/ml. Thus, in general, the anti-inflammatory activity of Dox was higher as compared to that of Mino, although the radical scavenging activity of Mino was of a magnitude 10 times higher. CONCLUSIONS: Our data indicate that anti-inflammatory and antioxidant effects, involve the inhibition of iNOS and TNF-alpha, among other properties, and these encourage clinical studies of these compounds for new therapeutic applications, especially those were inflammation plays a role.
Authors: Annemarie Ledeboer; Evan M Sloane; Erin D Milligan; Matthew G Frank; John H Mahony; Steven F Maier; Linda R Watkins Journal: Pain Date: 2005-05 Impact factor: 6.961
Authors: Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander Journal: Nature Date: 2002-05-02 Impact factor: 49.962
Authors: S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman Journal: Cancer Chemother Pharmacol Date: 1995 Impact factor: 3.333
Authors: S Bombardieri; P Cattani; G Ciabattoni; O Di Munno; G Pasero; C Patrono; E Pinca; F Pugliese Journal: Br J Pharmacol Date: 1981-08 Impact factor: 8.739
Authors: Abdulrahman Al Asmari; Saud Al Omani; Malfi Al Otaibi; Abdul-Aziz Al Abdulaaly; Ibrahim Elfaki; Khalid Al Yahya; Mohammed Arshaduddin Journal: Int J Clin Exp Med Date: 2014-03-15
Authors: Hector R Galván-Salazar; Alejandro D Soriano-Hernández; Daniel A Montes-Galindo; Gabriel Ceja Espíritu; José Guzman-Esquivel; Iram P Rodríguez-Sánchez; Oscar A Newton-Sánchez; Margarita L Martinez-Fierro; Xóchitl G Briseño Gómez; Augusto Rojas-Martínez; Iván Delgado-Enciso Journal: Mol Clin Oncol Date: 2016-09-08
Authors: Ivan Delgado-Enciso; Alejandro García-Rivera; M Violeta M Madrigal-Pérez; Alejandrina Rodriguez-Hernandez; Agustin Lugo-Radillo; Hector R Galvan-Salazar; Alejandro D Soriano-Hernández; Fernando Gómez-Tapia; Rafael Martinez-Martinez; Laura L Valdez-Velazquez; Oscar A Newton-Sanchez; Rafael Gonzalez-Alvarez; Iram P Rodriguez-Sanchez; Valery Melnikov; Agustin Lara-Esqueda; Jose Guzman-Esquivel Journal: Int Urol Nephrol Date: 2013-11-28 Impact factor: 2.370
Authors: Joshua A Shapiro; Samuel AbuMoussa; Christopher P Lindsay; Gabriel B Mason; Laurence E Dahners; Paul S Weinhold Journal: J Orthop Date: 2019-12-12